

More than simply replenishing collagen lost due to aging and environmental stress, Atelocollagen provides immediate volumizing support while helping reinforce the skin’s structural foundation for a firmer, fuller, and healthier-looking appearance.

Natural yet powerful raw material, Atelocollagen, meets CE and ISO 13485 standards.
Formulated with 99% Collagen for versatile use, delivering a skin-boosting and volumizing effect.
Immunogenicity minimized through enzymatic refinement and advanced multi-filtration.
Human-like collagen, purified in a non-crosslinked state, enriches the skin’s ECM environment. Utilized via low-heat aseptic salt precipitation technique (Patent No. 10-1105603).

NOT ONLY
Volumizing filler

NOT A TYPICAL
Particulate biostimulator

DIRECT Injectable
ECM protein
Starting with the first registration at Uijeongbu St. Mary’s Hospital in 2016, it has been adopted by domestic university hospitals such as Seoul St. Mary’s Hospital, Seoul National University Hospital, Seoul National University Bundang Hospital, Seoul Asan Medical Center, and Samsung Seoul Medical Center, and as of the end of 2023, it’s registered in approximately 67 university hospitals in Korea.




Type I atelocollagen is treated with pepsin to remove telopeptides, reducing immunogenicity while preserving collagen’s structure and function.
BCollagen is made of two α1 chains and one α2 chain, with telopeptides at both ends, which increase immunogenicity.
Of the 28 known types, Type I is the most abundant. It weighs ~300 kDa and has three polypeptide chains.




The thick, structured Atelocollagen matrix provides strong support for the skin while replenishing collagen lost over time. It helps restore a healthy skin environment, reinforcing skin structure and bringing it back to a healthier condition with a natural-looking effect.